Article Details
Retrieved on: 2021-04-01 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The variant from South Africa, for example, reduced Pfizer-BioNTech's antibody protection by two-thirds, according to a February study. Moderna's ...
Article found on: www.nbcchicago.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here